Literature DB >> 24018641

Knockdown of CRM1 inhibits the nuclear export of p27(Kip1) phosphorylated at serine 10 and plays a role in the pathogenesis of epithelial ovarian cancer.

You Wang1, Yingying Wang2, Jingying Xiang3, Fang Ji4, Yan Deng2, Chunhui Tang2, Shuyun Yang2, Qinghua Xi2, Rong Liu5, Wen Di6.   

Abstract

In a previous study, the nuclear export protein chromosomal region maintenance (CRM1) was correlated with p27(Kip1) in glioma. The aims of the present study were to investigate the expression of CRM1 and pSer10p27 and their functional roles in epithelial ovarian cancer (EOC) tissues. Using immunohistochemical analysis, CRM1 and pSer10p27 expression levels were shown to be associated with histologic stage and grade (P<0.05). High CRM1 and pSer10p27 expression levels were prognostic indicators of overall survival (P<0.05). Knockdown of CRM1 and pSer10p27 expression arrested cell cycle progression and inhibited the proliferation of SKOV3 cells both in vitro and in vivo. These data support the idea that pSer10p27 and CRM1 play cooperative roles in EOC.
Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Chromosomal region maintenance; Epithelial ovarian cancer; Phosphorylation; Proliferation; p27(Kip1)

Mesh:

Substances:

Year:  2013        PMID: 24018641     DOI: 10.1016/j.canlet.2013.09.002

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  22 in total

1.  Novel reversible selective inhibitor of nuclear export shows that CRM1 is a target in colorectal cancer cells.

Authors:  Mingshan Niu; Yulong Chong; Yan Han; Xuejiao Liu
Journal:  Cancer Biol Ther       Date:  2015-05-21       Impact factor: 4.742

2.  PKC iota promotes cellular proliferation by accelerated G1/S transition via interaction with CDK7 in esophageal squamous cell carcinoma.

Authors:  Sujie Ni; Lingling Chen; Mei Li; Weijuan Zhao; Xiaohang Shan; Miaomiao Wu; Jialin Cheng; Li Liang; Yayun Wang; Wenyan Jiang; Jianguo Zhang; Runzhou Ni
Journal:  Tumour Biol       Date:  2016-08-01

3.  JAB1 and phospho-Ser10 p27 expression profile determine human hepatocellular carcinoma prognosis.

Authors:  You Wang; Ya-Nan Yu; Shu Song; Tie-Jun Li; Jing-Ying Xiang; Hong Zhang; Mu-Dan Lu; Fang Ji; Ling-Qing Hu
Journal:  J Cancer Res Clin Oncol       Date:  2014-03-27       Impact factor: 4.553

4.  Knockdown of DIXDC1 Inhibits the Proliferation and Migration of Human Glioma Cells.

Authors:  Jianguo Chen; Chaoyan Shen; Jinlong Shi; Jianhong Shen; Wenjuan Chen; Jie Sun; Shaocheng Fan; Yuanqi Bei; Peng Xu; Hao Chang; Rui Jiang; Lu Hua; Bin Ji; Qingfeng Huang
Journal:  Cell Mol Neurobiol       Date:  2016-11-05       Impact factor: 5.046

5.  High Expression of BCCIP β Can Promote Proliferation of Esophageal Squamous Cell Carcinoma.

Authors:  Lingling Chen; Sujie Ni; Mei Li; Chaoyan Shen; Zhipeng Lin; Yu Ouyang; Fei Xia; Li Liang; Wenyan Jiang; Runzhou Ni; Jianguo Zhang
Journal:  Dig Dis Sci       Date:  2016-12-19       Impact factor: 3.199

6.  Gambogic acid inhibits the growth of ovarian cancer tumors by regulating p65 activity.

Authors:  Qiusha Tang; Mudan Lu; Huan Zhou; Daozhen Chen; Lu Liu
Journal:  Oncol Lett       Date:  2016-11-24       Impact factor: 2.967

Review 7.  Oncogenic role of p21 in hepatocarcinogenesis suggests a new treatment strategy.

Authors:  Shogo Ohkoshi; Masahiko Yano; Yasunobu Matsuda
Journal:  World J Gastroenterol       Date:  2015-11-14       Impact factor: 5.742

8.  Overexpression of MYCN promotes proliferation of non-small cell lung cancer.

Authors:  Kun Liu; Shuo Wang; Yifei Liu; Jun Gu; Shudong Gu; Zhen Xu; Rui Zhang; Zhiwen Wang; Huaci Ma; Yingying Chen; Lili Ji
Journal:  Tumour Biol       Date:  2016-07-23

9.  CDK14 involvement in proliferation migration and invasion of esophageal cancer.

Authors:  Lingling Chen; Yayun Wang; Wenyan Jiang; Runzhou Ni; Yuchan Wang; Sujie Ni
Journal:  Ann Transl Med       Date:  2019-11

10.  Novel reversible selective inhibitor of CRM1 for targeted therapy in ovarian cancer.

Authors:  Xuejiao Liu; Yulong Chong; Huize Liu; Yan Han; Mingshan Niu
Journal:  J Ovarian Res       Date:  2015-06-10       Impact factor: 4.234

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.